COMMUNIQUÉS West-GlobeNewswire

Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
02/09/2025
Ethereum to Enhance Multi-Faceted Corporate Strategy of Cryptocurrency Exposure, Pharmaceutical Drug Development & Asset Acquisition MELBOURNE, Australia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( [...]
Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
02/09/2025
Live webcast presentation with Co-Founder and CEO, Dr. Timothy Lu, on September 8th at 2:00 PM ET SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a [...]
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
02/09/2025
DUBLIN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable [...]
Perfusion Life Approved as GSA Vendor, Enhancing Cardiac Perfusion Staffing for VA Hospitals
02/09/2025
Raleigh, North Carolina, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Perfusion Life , a nationally recognized provider of joint-commission accredited perfusion staffing, has been approved as a vendor on the General Services [...]
Precipio Terminates Its ATM
02/09/2025
Management Decision Further Reinforces Commitment to Responsible Capital Management NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , has [...]
Lighthouse Autism Center Affirms Commitment to Nebraska Families Following Medicaid Rate Cuts
02/09/2025
MISHAWAKA, Ind., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center announced today it will continue to provide Applied Behavior Analysis (ABA) therapy to Nebraska families despite a recent 48% reduction in [...]
Military Veterans Join Virtue Recovery to Expand Community Outreach with Hope and Support
02/09/2025
LAS VEGAS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Virtue Recovery is proud to announce the expansion of its Business Development Team with the addition of two U.S. military veterans: Adam Khosroabadi, U.S. Marine Corps [...]
Dianabol (Dbol) Pills 2025: DBal Max Launch Dianabol Anabolic Legal Steroid Alternatives for Beginners Dosage Usage, Benefits & Results
02/09/2025
Dianabol (D-bol) Pills for Muscle Growth: Read Benefits, Dianabol Side Effects, Results, and advanced Alternatives Pills From D-Bal Max new york, Sept. 02, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 | New York, (Dbal Max [...]
Trading by management and close relations of management
02/09/2025
Please read the announcement in PDF Attachment 2025_43_Trading_By_Management
FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
02/09/2025
Total consideration for the sale of FibroGen China to AstraZeneca is approximately $220 million, a $60 million increase from initial guidance Successfully repaid term loan to Morgan Stanley Tactical Value, further [...]
Seer Appoints Isaac Ro to its Board of Directors
02/09/2025
REDWOOD CITY, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced it has appointed Isaac Ro to serve on its Board [...]
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
02/09/2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics [...]
Kamada to Participate in Upcoming September Investor Conferences
02/09/2025
REHOVOT, Israel, and HOBOKEN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious [...]
AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases
02/09/2025
Two new milestone publications confirm robust efficacy and safety profile of bio-Interventional uveoscleral outflow enhancement technology WHITE PLAINS, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc. today [...]
Neumora Therapeutics to Participate in Upcoming Conferences in September
02/09/2025
WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel [...]
Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study
02/09/2025
Skye also announces completion of enrollment of 26‑week extension study; 52‑week data planned, with post‑extension 13‑week follow‑up SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“ [...]
Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer
02/09/2025
Study to explore the palazestrant-atirmociclib combination in approximately 35 patients with initiation anticipated in H2 2025 Results to inform potential pivotal Phase 3 trial of novel combination in frontline [...]
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
02/09/2025
WEST CHESTER, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical [...]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
02/09/2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that [...]

Pages